COVID-19: Research updates, October 13 • A new study links COVID-19 to significantly higher dementia risk in older adults with type 2 diabetes. • SARS-CoV-2-specific monoclonal antibody AER002 failed a Long COVID trial. • FDA cleared a new Phase 2 trial of botanical drug FRP-003 for Long COVID.
Research updates, October 13 - The Sick Times
A new study found COVID-19 was linked to a significant increase in dementia in older people with type 2 diabetes. The retrospective study published in Frontiers in Aging Neuroscience included a cohort...
thesicktimes.org